U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

Cost-Utility Analysis of Cancer Prevention, Treatment, and Control

Supporting Files
File Language:
English


Details

  • Alternative Title:
    Am J Prev Med
  • Personal Author:
  • Description:
    Context ; Substantial innovation related to cancer prevention and treatment has occurred in recent decades. However, these innovations have often come at a significant cost. Cost-utility analysis provides a useful framework to assess if the benefits from innovation are worth the additional cost. This systematic review on published cost-utility analyses related to cancer care is from 1988 through 2013. Analyses were conducted in 2013–2015. ; Evidence acquisition ; This review analyzed data from the Tufts Medical Center Cost-Effectiveness Analysis Registry (www.cearegistry.org), a comprehensive registry with detailed information on 4,339 original cost-utility analyses published in the peer-reviewed medical and economic literature through 2013. ; Evidence synthesis ; There were 721 cancer-related cost-utility analyses published from 1998 through 2013, with roughly 12% of studies focused on primary prevention and 17% focused on secondary prevention. The most often studied cancers were breast cancer (29%); colorectal cancer (11%); and prostate cancer (8%). The median reported incremental cost-effectiveness ratios (in 2014 U.S. dollars) were $25,000 for breast cancer, $24,000 for colorectal cancer, and $34,000 for prostate cancer. ; Conclusions ; The current evidence indicates that there are many interventions that are cost effective across cancer sites and levels of prevention. However, the results highlight the relatively small number of cancer cost-utility analyses devoted to primary prevention compared with secondary or tertiary prevention.
  • Subjects:
  • Source:
    Am J Prev Med. 50(2):241-248
  • Pubmed ID:
    26470806
  • Pubmed Central ID:
    PMC5846573
  • Document Type:
  • Funding:
  • Volume:
    50
  • Issue:
    2
  • Download URL:
  • File Type:
    Filetype[PDF - 262.38 KB]
  • Collection(s):
  • Main Document Checksum:
    urn:sha256:3b4309090cc588bdfdd03de95b467a688baa6dc89994ebfe8c2b61987c69dd43
File Language:
English
ON THIS PAGE
 Was this page helpful?
 Found an issue?
Send us an email at:
CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.